(Total Views: 613)
Posted On: 12/21/2020 6:42:42 PM
Post# of 148939
From turning stone on another board:
This is a response from D. Scott Kelly of CytoDyn after I emailed him to ask if LL would work on the new strain of covid.
Original Message
From: Scott Kelly <skelly@cytodyn.com>
To: xxxxxxxxxxx
Cc: "Nader Z. Pourhassan" <npourhassan@cytodyn.com>
Date: 12/21/2020 9:19 AM
Subject: leronlimab
Robert,
The mutation would not affect leronlimab’s ability to work on the CCR5 pathway.
Best,
Scott A. Kelly, M.D.
This is a response from D. Scott Kelly of CytoDyn after I emailed him to ask if LL would work on the new strain of covid.
Original Message
From: Scott Kelly <skelly@cytodyn.com>
To: xxxxxxxxxxx
Cc: "Nader Z. Pourhassan" <npourhassan@cytodyn.com>
Date: 12/21/2020 9:19 AM
Subject: leronlimab
Robert,
The mutation would not affect leronlimab’s ability to work on the CCR5 pathway.
Best,
Scott A. Kelly, M.D.
(3)
(0)Scroll down for more posts â–¼
